Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Challenges in drug discovery for novel antifilarials.

Townson S, Ramirez B, Fakorede F, Mouries MA, Nwaka S.

Expert Opin Drug Discov. 2007 Oct;2(s1):S63-73. doi: 10.1517/17460441.2.S1.S63.

PMID:
23489034
2.

Elimination of lymphatic filariasis: do we have the drugs to complete the job?

Bockarie MJ, Deb RM.

Curr Opin Infect Dis. 2010 Dec;23(6):617-20. doi: 10.1097/QCO.0b013e32833fdee5. Review.

PMID:
20847694
3.

Drug treatment of tropical parasitic infections: recent achievements and developments.

Stephenson I, Wiselka M.

Drugs. 2000 Nov;60(5):985-95. Review.

PMID:
11129130
4.

[ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].

Chanteau S, Roux JF.

Bull Soc Pathol Exot. 2008 Jun;101(3):254-60. French.

PMID:
18681220
6.

Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.

Burkot TR, Taleo G, Toeaso V, Ichimori K.

Ann Trop Med Parasitol. 2002 Dec;96 Suppl 2:S61-9.

PMID:
12625919
7.

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.

Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Richard-Lenoble D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV.

Parasitology. 2000;121 Suppl:S147-60. Review.

PMID:
11386686
9.

The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).

Hooper PJ, Bradley MH, Biswas G, Ottesen EA.

Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S17-21. doi: 10.1179/000349809X12502035776513.

PMID:
19843394
10.
11.

Treatment strategies underpinning the global programme to eliminate lymphatic filariasis.

Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA.

Expert Opin Pharmacother. 2005 Feb;6(2):179-200. Review.

PMID:
15757416
12.

Modelling the epidemiology, transmission and control of lymphatic filariasis.

Das PK, Subramanian S.

Ann Trop Med Parasitol. 2002 Dec;96 Suppl 2:S153-64.

PMID:
12625928
13.

The development of albendazole for lymphatic filariasis.

Horton J.

Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S33-40. doi: 10.1179/000349809X12502035776595. Review.

PMID:
19843396
15.
16.

Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.

Hoerauf A.

Curr Opin Infect Dis. 2008 Dec;21(6):673-81. doi: 10.1097/QCO.0b013e328315cde7. Review.

PMID:
18978537
17.

Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.

Kshirsagar NA, Gogtay NJ, Garg BS, Deshmukh PR, Rajgor DD, Kadam VS, Kirodian BG, Ingole NS, Mehendale AM, Fleckenstein L, Karbwang J, Lazdins-Helds JK.

Trans R Soc Trop Med Hyg. 2004 Apr;98(4):205-17. Erratum in: Trans R Soc Trop Med Hyg. 2004 May;98(5):329.

PMID:
15049459
18.

Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Jul 29;60(29):989-91.

19.

Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.

De Rochars MB, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ.

Am J Trop Med Hyg. 2004 Oct;71(4):466-70.

PMID:
15516644
20.

Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.

Anto F, Asoala V, Anyorigiya T, Oduro A, Adjuik M, Akweongo P, Aborigo R, Bimi L, Amankwa J, Hodgson A.

Trop Med Int Health. 2011 Sep;16(9):1112-9. doi: 10.1111/j.1365-3156.2011.02814.x. Epub 2011 Jun 20.

Supplemental Content

Support Center